BofA raised the firm’s price target on AptarGroup (ATR) to $147 from $142 and keeps a Neutral rating on the shares. Following Q4, the firm trimmed 2026 estimates and rolled valuation assumptions to its revised 2026 estimates.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATR:
- AptarGroup price target raised to $156 from $145 at Baird
- Balanced View on AptarGroup: Solid Underlying Pharma Performance Offset by Near-Term Headwinds and Underwhelming Beauty & Closures, Justifying a Hold Rating
- AptarGroup sees Q1 adjusted EPS $1.13-$1.21, consensus $1.23
- AptarGroup reports Q4 adjusted EPS $1.25, consensus $1.23
- ATR Earnings this Week: How Will it Perform?